1、Technology:Indoline derivatives for treatment and/or prevention of tumor or cell proliferatinve and fibrosid diseases
2、Provider:Prof. Chia-Ron Yang School of Pharmacy, College of Medicine, NTU
3、Enterprise Eligibility:
(1). Industry Category: Biotechnology and medicine
(2). Required Technical Know-how: New drug development
(3). Required Machinery and Equipment:None
(4). Required Research or Technical Staff:New drug development
(5). Other Requirements:None
4.How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.
5.Announcement period:From the announcement date to 2024/2/7, late applications will not be accepted. Those who send materials by mail shall use the postmark as evidence.
Intellectual Property & Licensing Manager: Lute Pan
TEL: +886-2-33669951
Email: lutepan@ntu.edu.tw